{
    "physical_examinations": [
        {
            "date": "December 2007",
            "vital_signs": "Not specified",
            "relevant_findings": "Pain resolved and mobility improved with teriparatide treatment.",
            "changes_over_time": "Initial clinical improvement with pain resolution and increased mobility was noted within the first 7 months of treatment."
        },
        {
            "date": "August 2008",
            "vital_signs": "Not specified",
            "relevant_findings": "Complete healing of the pseudofracture of the right femur, and bony callus was seen on the left.",
            "changes_over_time": "Clinical improvements continued with notable radiological evidence of increased bone mineralization."
        },
        {
            "date": "January 2009",
            "vital_signs": "Not specified",
            "relevant_findings": "Teriparatide treatment was stopped due to the decline in serum ALP and increase in urine PEA and serum PLP.",
            "changes_over_time": "Biochemical deterioration was noted between 8 and 13 months of teriparatide treatment."
        },
        {
            "date": "March 2009",
            "vital_signs": "Not specified",
            "relevant_findings": "Pain in the right thigh was reported, and a radiograph showed the pseudofracture of the right femur was now visible after having completely healed.",
            "changes_over_time": "The patient continued to experience pain despite previously reported improvements."
        },
        {
            "date": "Not specified",
            "vital_signs": "Not specified",
            "relevant_findings": "Initial measurements of serum ALP prior to teriparatide were persistently low (3 to 8 IU/liter).",
            "changes_over_time": "Indicators showed a decline in serum ALP and increases in urine PEA and serum PLP over time."
        }
    ]
}